KIYATEC Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:KIYATEC Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11165
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
KIYATEC Inc (KIYATEC) is a biotechnology company that commercializes 3D cell culture technology. The company concentrates on data correlation to human clinical outcomes. It provides drug response profiling services for developing small molecule compounds and biologic drugs. KIYATEC offers custom 3D cell based models that are used in preclinical evaluation of compounds and biologics. The company provides predictive drug response profiles for both acute and chronic dosing strategies for the precise tissues. The company’s project 3D perfusion co-culture models are used for breast cancer, lung cancers and GBM. It caters to pharmaceutical, biomedical, life science industries, and others. KIYATEC is headquartered in Greenville, South Carolina, the US.

KIYATEC Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
KIYATEC Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
KIYATEC Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
KIYATEC Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
KIYATEC Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
KIYATEC Inc, Medical Devices Deals, 2012 to YTD 2018 9
KIYATEC Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
KIYATEC Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
KIYATEC Raises USD3 Million in Venture Financing 11
Kiyatec Raises US$2.8 Million In Series A Financing 12
Partnerships 13
KIYATEC Enters into Research Contract with National Cancer Institute 13
KIYATEC Inc – Key Competitors 14
KIYATEC Inc – Key Employees 15
KIYATEC Inc – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
KIYATEC Inc, Pharmaceuticals & Healthcare, Key Facts 2
KIYATEC Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
KIYATEC Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
KIYATEC Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
KIYATEC Inc, Deals By Therapy Area, 2012 to YTD 2018 8
KIYATEC Inc, Medical Devices Deals, 2012 to YTD 2018 9
KIYATEC Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
KIYATEC Raises USD3 Million in Venture Financing 11
Kiyatec Raises US$2.8 Million In Series A Financing 12
KIYATEC Enters into Research Contract with National Cancer Institute 13
KIYATEC Inc, Key Competitors 14
KIYATEC Inc, Key Employees 15

List of Figures
KIYATEC Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
KIYATEC Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
KIYATEC Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
KIYATEC Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
KIYATEC Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
KIYATEC Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
KIYATEC Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
KIYATEC Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
KIYATEC Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[KIYATEC Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Albéa Beauty Holdings S.A.:戦略・SWOT・企業財務分析
    Albéa Beauty Holdings S.A. - Strategy, SWOT and Corporate Finance Report Summary Albéa Beauty Holdings S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Grupo Elektra, S.A. de C.V.:企業の戦略・SWOT・財務分析
    Grupo Elektra, S.A. de C.V. - Strategy, SWOT and Corporate Finance Report Summary Grupo Elektra, S.A. de C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • National Autonomous University of Mexico:企業の戦略的SWOT分析
    National Autonomous University of Mexico - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • SBI Pharmaceuticals Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary SBI Pharmaceuticals Co Ltd (SBI Pharma), formerly SBI Alapromo Co Ltd, a subsidiary of SBI Holdings Inc, is a healthcare solution provider that develops and manufactures 5-ALA (5-Aminolevulinic Acid) based products in the areas of medicines for cancer cell identification and cancer diagnosis …
  • Generali Deutschland AG:企業の戦略・SWOT・財務情報
    Generali Deutschland AG - Strategy, SWOT and Corporate Finance Report Summary Generali Deutschland AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Enercon Services Inc:企業の戦略的SWOT分析
    Enercon Services Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Radius Health Inc (RDUS):製薬・医療:M&Aディール及び事業提携情報
    Summary Radius Health Inc (Radius Health), formerly NuVios, Inc., is a biopharmaceutical company that develops and commercializes therapeutics for osteoporosis, oncology and endocrine diseases. The company’s product includes abaloparatide injection, which is used for the treatment of postmenopausal …
  • Arkansas Children’s Hospital:企業の戦略的SWOT分析
    Arkansas Children's Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • United Networks Ltd (UNL):企業の財務・戦略的SWOT分析
    United Networks Ltd (UNL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Hey-Song Corporation:企業の戦略・SWOT・財務情報
    Hey-Song Corporation - Strategy, SWOT and Corporate Finance Report Summary Hey-Song Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Thaivivat Insurance Public Company Limited:企業の戦略・SWOT・財務分析
    Thaivivat Insurance Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Thaivivat Insurance Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Precision System Science Co Ltd (7707)-医療機器分野:企業M&A・提携分析
    Summary Precision System Science Co Ltd (PSS) is a medical device company that develops, manufactures and sells automated systems, physicochemical instruments, software, and others. The company’s products include automated nucleic acid isolation system, large sample volume nucleic acid extraction sy …
  • SK Telecom Co., Ltd.:企業の戦略・SWOT・財務分析
    SK Telecom Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary SK Telecom Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Innate Pharma SA (IPH):企業の財務・戦略的SWOT分析
    Summary Innate Pharma SA (Innate Pharma) is a biotechnology company developing antibodies to treat cancer by harnessing the immune system. It offers Lumoxiti, a CD22-directed immunotoxin for the treatment of relapsed or refractory hairy cell leukemia (HCL). The company is investigating drugs against …
  • Lundin Gold Inc:戦略・SWOT・企業財務分析
    Lundin Gold Inc - Strategy, SWOT and Corporate Finance Report Summary Lundin Gold Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Compagnie Financiere Richemont SA:戦略・SWOT・企業財務分析
    Compagnie Financiere Richemont SA - Strategy, SWOT and Corporate Finance Report Summary Compagnie Financiere Richemont SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Santhera Pharmaceuticals Holding AG:企業のM&A・事業提携・投資動向
    Santhera Pharmaceuticals Holding AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Santhera Pharmaceuticals Holding AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on …
  • Brady Corporation (BRC):企業の財務・戦略的SWOT分析
    Brady Corporation (BRC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Black Hills Corporation (BKH):石油・ガス:M&Aディール及び事業提携情報
    Summary Black Hills Corp (BHC) is a vertically-integrated energy company which offers electricity and natural gas. The company produces, transmits, and distributes electricity; and sells natural gas on retail and wholesale basis. It generates electricity from natural gas, coal, diesel oil, and wind …
  • Aviva Poland:企業の戦略・SWOT・財務情報
    Aviva Poland - Strategy, SWOT and Corporate Finance Report Summary Aviva Poland - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆